Citi analyst Christopher Allen lowered the firm’s price target on CME Group to $210 from $214.29 and keeps a Buy rating on the shares. The analyst refreshed estimates for the brokers and asset managers ahead of Q4 earnings. Overall, he continues to favor the exchanges over the brokers at present given his expectations for a "choppy" equity market in 2023. The analyst sees the exchanges as more defensive plays.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CME:
- CME Group price target lowered to $200 from $207 at Deutsche Bank
- CME Group reports International ADV of 6.3M contracts in 2022, up 15% y/y
- CME Group price target lowered to $220 from $226 at UBS
- CME Group upgraded to Outperform from Neutral at Credit Suisse
- CME Group says ADV increased 7% in December to 19.2M contracts